#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extra-osseous Ewing's sarcoma Acute respiratory distress syndrome Thalassaemia alpha Prophylaxis against transplant rejection Carcinoid syndrome Pleural mesothelioma malignant Superficial vein thrombosis Prostate cancer Cystic fibrosis lung Neutropenia Mixed-type liposarcoma Microvillous inclusion disease C3 glomerulopathy Optic glioma Facioscapulohumeral muscular dystrophy More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Trials in Disease Metachromatic leukodystrophy – Treatment Castleman’s disease – Basic Information Choroid melanoma – Treatment Alport’s syndrome – Diagnostics Haemophagocytic lymphohistiocytosis – Life with Disease Immunodeficiency congenital Haemophilia A with anti factor VIII Alternating hemiplegia of childhood – Life with Disease Burkitt’s lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sulfonamides, Urea Derivatives Clemastine Fumarate Elasomeran VERCIRNON Sulfasalazine Gskvx000000017033 Alxn1850 Posaconazole Autologous Chondrocytes Daxdilimab His203-Crm197 TRIGLYCERIDES MEDIUM CHAIN Disitamab Vedotin Ucart22 Ursodoxicoltaurine Lenalidomide Carbamazepine Urokinase Dostarlimab Vigabatrin More therapies…

    Learn about Your Condition

    Hepatotoxicity Hypertension Retinopathy of prematurity Lumbosacral radiculopathy Renal injury Cardiogenic shock Diabetic retinopathy Large cell lung cancer stage 0 Weaning failure Thalassaemia alpha Thrombocytosis Chorea Plasma cell myeloma recurrent Spermatocele Pulmonary embolism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Migraine

  • Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

    Recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Austria Czechia Denmark France Germany Italy +3

  • A study to evaluate the safety and effectiveness of omalizumab in adults with episodic migraine

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Omalizumab
    Norway

  • Study on Atorvastatin for Preventing Episodic Migraine in Adults

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atorvastatin
    • Placebo
    Norway

  • Study on Atorvastatin for Preventing Chronic Migraine in Adults

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Atorvastatin
    • Placebo
    Norway

  • A Study of Erenumab Compared to Placebo for Children and Teenagers With Chronic Migraine to Test How Well It Works and How Safe It Is

    Not recruiting

    3 1
    Investigated Drugs:
    • Erenumab
    Belgium Germany Hungary Italy Poland

  • Study of Erenumab Compared to Placebo for Children and Adolescents with Episodic Migraine to Reduce Monthly Migraine Days

    Not recruiting

    3 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • Erenumab
    Belgium Germany Hungary Italy Poland Portugal +1
Previous Page
1 2 3 4 5 6 … 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!